Podcasts about diagnostics

Tick-borne diseases continue to expand across North America, but diagnosing them in the clinical laboratory remains complex—especially when timing between symptom onset and testing isn't considered. In this episode of Let's Talk Micro, Luis is joined by Kyle Rodino, Assistant Professor of Pathology and Laboratory Medicine at the University of Pennsylvania and Assistant Director of Microbiology, for a lab-focused discussion on tick-borne disease diagnostics. They cover major bacterial, parasitic, and viral causes of tick-borne disease, and walk through how molecular testing, serology, and microscopy are used at different stages of illness. The conversation highlights why test selection and timing matter, common diagnostic challenges—particularly with Babesia and Lyme disease testing—and how laboratories can support better diagnostic decision-making. A practical episode for microbiologists, laboratorians, and clinicians navigating real-world testing challenges in the lab.   Additional resources: Update on North American tick-borne diseases and how to diagnose them https://doi.org/10.1128/jcm.00807-23   Stay connected with Let's Talk Micro: Website: letstalkmicro.com Questions or feedback? Email me at letstalkmicro@outlook.com Interested in being a guest on Let's Talk Micro? Fill out the form here: https://forms.gle/V2fT3asjfyusmqyi8   Support the podcast: Venmo Buy me a Ko-fi  

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Eugene: Staying focused on a North Star.Eugene Chan, CEO and founder of rHEALTH, has taken blood diagnostics to new heights—literally. His innovative technology, capable of analyzing dozens of biomarkers from a single drop of blood, was tested aboard the International Space Station (ISS). In today's episode, Eugene shared the remarkable journey of rHEALTH, from competing with top companies for a NASA partnership to launching its device into space.What sets rHEALTH apart is its proven reliability in extreme conditions, including the zero-gravity environment of space. Eugene explained, “We tested this technology on the International Space Station with astronaut Samantha Cristoforetti, who operated the device and obtained precise values from single drops of sample. They did the analysis using our device and got absolutely the right answers.” This achievement underlines the robustness and accuracy of rHEALTH's technology, qualities that distinguish it from other attempts at single-drop blood diagnostics.Unlike Theranos, which famously failed to deliver on similar promises, rHEALTH's technology has been rigorously vetted. Eugene highlighted the grueling process of earning NASA's trust. “To be the one company selected to demonstrate our novel technology on the ISS was a huge undertaking,” he said. He recounted the intense competition and NASA's exacting standards, which included testing the device's functionality during zero-gravity parabolic flights.Now, Eugene and his team are bringing this groundbreaking technology to the public with a regulated crowdfunding campaign on StartEngine. “You don't have to be a Silicon Valley elite or a Boston venture capitalist to participate,” I noted during the episode. With this campaign, everyday investors have the opportunity to support a proven technology poised to revolutionize healthcare.The implications of rHEALTH's success are profound. If it works in space, it can work in remote clinics, underserved communities, and even in people's homes. This technology has the potential to make diagnostics more accessible, empowering individuals to take control of their health.Eugene's vision, combined with rHEALTH's proven track record, makes this an exciting investment opportunity. Visit StartEngine to learn more and become part of this revolutionary journey.tl;dr:Eugene Chan shared how rHEALTH's diagnostic technology was tested and proven aboard the International Space Station.He explained the rigorous process of competing with other companies to secure NASA's trust.rHEALTH's crowdfunding campaign on StartEngine makes investing in this revolutionary technology accessible to all.Eugene highlighted the importance of his North Star: improving human health with innovative solutions.He shared advice on maintaining focus and using challenges as opportunities to achieve big goals.How to Develop Staying Focused on a North Star As a SuperpowerEugene's superpower is his ability to maintain a relentless focus on his “North Star”—the overarching goal of improving human health. As he explained, “The North Star has always been to improve the human condition and help us improve human health.” For Eugene, this guiding principle has driven his work through challenges, from competing for NASA's attention to developing groundbreaking diagnostic technology.One illustrative story of this superpower came during a pivotal moment in Eugene's career. While competing in the XPRIZE competition, he found himself grappling with a flawed prototype. It was during this time, sitting at his wife's bedside after the birth of their child, that the concept for rHEALTH's current device was born. Combining the pressure of the competition, the inspiration of his newborn daughter, and his unwavering focus on creating a robust solution, Eugene developed the technology that would later achieve success in space.Eugene also shared actionable tips for developing this superpower:Identify your personal North Star—a goal or mission that deeply resonates with you.Let that North Star guide your decisions, especially during challenging times.Stay committed to your mission, even when facing setbacks or obstacles.Use external pressures, like deadlines or competitions, to fuel innovation and progress.By following Eugene's example and advice, you can make staying focused on a North Star a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileEugene Chan (he/him):CEO, Founder, rHEALTHAbout rHEALTH: rHEALTH has worked with NASA to develop a miniaturized diagnostic test system to keep astronauts healthy on the way to Mars. We have successfully tested this onboard the International Space Station and published the results in Nature Communications, demonstrating results from blood in minutes in extreme environments. The technology shrinks a central clinical lab and a team of doctors in a form suitable for everyday use. Comprehensive lab-quality analysis can be performed by anyone, fundamentally shifting diagnostics from centralized facilities to the point-of-care and homes. The focus is to usher in Diagnostics 2.0, allowing high-value multiplexed diagnostics.Website: rhealth.comOther URL: startengine.com/offering/rhealthBiographical Information: Dr. Chan is a physician-inventor. He is currently Founder, CEO of rHEALTH, and President, CSO of DNA Medicine Institute, a medical innovation laboratory. He has been honored as Esquire magazine's Best and Brightest, one of MIT Technology Review's Top 100 Innovators, and an XPRIZE winner. His work has contributed to the birth of next-generation sequencing, health monitoring in remote environments, and therapeutics. Dr. Chan holds over 60 patents and publications, with work funded by the NIH, NASA, and USAF. Dr. Chan received an A.B. in Biochemical Sciences from Harvard College summa cum laude in 1996, received an M.D. from Harvard Medical School with honors in 2007, and trained in medicine at the Brigham and Women's Hospital. He has been in zero gravity and led the team that demonstrated the rHEALTH ONE bioanalyzer onboard the International Space Station.LinkedIn Profile: linkedin.com/in/eugene-chan-4220045Personal Twitter Handle: @Dr_EugeneChanSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include Crowdfunding Made Simple. Learn more about advertising with us here.Max-Impact Members(We're grateful for every one of these community champions who make this work possible.)Brian Christie, Brainsy | Cameron Neil, Lend For Good | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Justin Starbird, The Aebli Group | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Mike Green, Envirosult | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.SuperGreen Live, January 22–24, 2026, livestreaming globally. Organized by Green2Gold and The Super Crowd, Inc., this three-day event will spotlight the intersection of impact crowdfunding, sustainable innovation, and climate solutions. Featuring expert-led panels, interactive workshops, and live pitch sessions, SuperGreen Live brings together entrepreneurs, investors, policymakers, and activists to explore how capital and climate action can work hand in hand. With global livestreaming, VIP networking opportunities, and exclusive content, this event will empower participants to turn bold ideas into real impact. Don't miss your chance to join tens of thousands of changemakers at the largest virtual sustainability event of the year. Learn more about sponsoring the event here. Interested in speaking? Apply here. Support our work with a tax-deductible donation here.SuperCrowd Impact Member Networking Session: Impact (and, of course, Max-Impact) Members of the SuperCrowd are invited to a private networking session on January 27th at 1:30 PM ET/10:30 AM PT. Mark your calendar. We'll send private emails to Impact Members with registration details.Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Join C-AR Annual Reporting: Requirements, Deadlines, and Lessons Learned from the Field on January 14, 2026, an informative online webinar designed to help crowdfunding issuers and professionals clearly understand C-AR annual reporting requirements, key deadlines, and real-world insights to stay compliant and prepared.Join UGLY TALK: Women Tech Founders in San Francisco on January 29, 2026, an energizing in-person gathering of 100 women founders focused on funding strategies and discovering SuperCrowd as a powerful alternative for raising capital.If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.Manage the volume of emails you receive from us by clicking here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss 2026 trends. Together, they explore:  JP Morgan Healthcare Conference (00:34): Dr. Morice shares his top observations and takeaways after attending this year's conference. Artificial intelligence (06:02): Anticipated benefits and risks of AI developments predicted in 2026.Reimbursement and regulation (13:43): Why reimbursement and regulation continue to be areas of significant interest in clinical diagnostics. Note: Information in this post was accurate at the time of its posting.ResourcesTransforming laboratory medicine through AI: From promise to practice"Answers From the Lab" podcast: Breakthroughs and Trends That Defined Lab Medicine in 2025"Answers From the Lab" podcast: PAMA Update and Accelerating Research and Development With BioPharma Diagnostics

On this episode Lara and Vyanka talk to Professor Alex Richter from the University of Birmingham all about Precision Diagnostics in Immunology. This is ImmunoTea: Your Immunology Podcast, presented by Dr Lara Dungan and Dr Vyanka Redenbaugh. This is the show where we tell you all about the most exciting research going on in the world of immunology. So grab a cup of tea, sit down and relax and we'll fill you in. Contact us at ImmunoTeaPodcast@gmail.com or @ImmunoTea on twitter. Hosted on Acast. See acast.com/privacy for more information.

Trois diagnostics en quelques mois, une maladie rare et une vie loin de la France.Dans ce premier épisode de Tuile d'Expat', Nelly Funk raconte son parcours avec un diabète cétodépendant, une forme encore méconnue, même de certains professionnels de santé.Diagnostiquée à Londres, elle a dû apprendre à naviguer dans un système médical étranger, faire ses propres recherches et devenir patiente experte pour comprendre ce que son corps vivait réellement.Un témoignage intime et éclairant sur le diabète, le poids des étiquettes médicales, la nécessité de s'informer et la réalité du quotidien avec une maladie chronique quand on est expatriée.Les ressources dont Nelly parle dans les épisodes sont les suivantes :Le compte insta de Diabetic Doctor : https://www.instagram.com/temidiabeticdoctor?igsh=eHV4a2FwMzlhbTZhLe compte insta insuleoin : https://www.instagram.com/insuleoin?igsh=MWZzeThnMWg3MmV0Zg==Le compte insta de Mathew L Carter : https://www.instagram.com/mathewlcarter?igsh=ZWxzZTFhZm9xM2p6Une mini-série rendue possible grâce au soutien de la CFE.French Expat est un podcast de French Morning qui raconte les parcours de vie des Français établis hors de France. Retrouvez-le sur toutes les plateformes d'écoute : Spotify, Apple Podcast, Deezer, Google Podcast, Podcast Addict, Amazon Music. Cet épisode est raconté, produit et réalisé par Anne-Fleur Andrle, habillé et mixé par Alice Krief. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

The Impact of Gaze and Fatigue on Medical Decision-Making with Dr. Bulat IbragimovIn this episode of The Girl Doc Survival Guide, Christine interviews Dr. Bulat Ibragimov, an Associate Professor of Machine Learning and Medical Imaging at the University of Copenhagen. Dr. Ibragimov shares personal anecdotes and discusses his research on the role of artificial intelligence and eye tracking in medical decision-making. Key topics include the impact of gaze patterns and fatigue on diagnostic accuracy, the potential for AI to recognize when doctors may make errors, and how individualized gaze patterns can indicate the level of expertise and certainty in medical professionals. The conversation explores the implications of this research for improving the integration of AI in medical practices and enhancing training and decision-making processes for healthcare professionals.00:00 Introduction and Guest Introduction00:49 Personal Anecdote and Background01:46 Eye Tracking and Medical Decision Making03:18 Patterns in Gaze and Error Prediction11:00 Fatigue and Its Impact on Accuracy16:09 AI and Gaze Analysis in Medical Training20:07 Conclusion and Final Thoughts

Lauren Rosenberg, a highly experienced Physician Associate, has dedicated nearly two decades to Internal Medicine and Health Optimization. Driven by a passion for preventative care, Lauren founded Vent Health to shift the focus from disease treatment to prevention. She specializes in a personalized approach that blends genetics, epigenetics, biomarkers, and lifestyle factors to tailor health interventions that extend and optimize each patient's healthspan. Lauren's practice includes prescribing peptides (GLP, CLP/GIP) for weight loss, insulin resistance, pre-diabetes, etc. This episode concentrates on all the questions about GLP's, the prescription based Ozempic and others, as well as the Compound Pharmacy GLP's that can often times be less expensive. Heather and Lauren also cover the common side effects, and how to manage them. In this episode you will learn other health benefits of these peptides, and who can benefit from them as well as practical tips for getting started on GLP-1 Therapy. Lauren is a frequent speaker at the Age Management Medicine Group (AMMG) and the American Academy of Anti-Aging Medicine (A4M) conferences. Lauren's practice includes Cardiology prevention: Diagnostics and AI analysis to detect dangerous plaque and calcium; advanced lipid testing and cardiovascular genetics Longevity biomarkers: DNA methylation for biological age, VO2 max testing, Telomere health; Therapeutic plasma exchange Cancer prevention: methylated DNA screens, preventative MRIs, tumor marker testing. We will have Lauren back to discuss all these other longevity and optimum health subjects. This episode concentrates on the information pertaining to Peptides, GLP's etc as they are so popular right now. If you want to contact Lauren for more info, you can reach her via her site: https://myventhealth.com and go to the contact page. Or email: vent@myventhealth.com Website: www.heatherthomson.com Social Media: IG: https://www.instagram.com/iamheathert/ You Tube: https://youtube.com/@iamheathert?si=ZvI9l0bhLfTR-qdo Learn more about your ad choices. Visit megaphone.fm/adchoices

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com At-home blood testing is moving diagnostics out of clinics and into people's lives, removing friction while expanding access to critical health insights. In this episode, Michael Dubrovsky, co-founder and CEO of SiPhox Health, discusses how his team is reimagining blood testing through painless at-home collection and advanced diagnostics focused on longevity and overlooked biomarkers. He explains why traditional blood testing in the U.S. is burdened by complexity, how SiPhox fills gaps left by primary care, and the growing consumer demand for deeper health data. Michael shares the origins of the company's silicon photonics technology, the challenges of clinician trust and FDA clearance, and how home testing is already saving lives by identifying conditions like heart disease and hemochromatosis earlier. He also explores B2B use cases, funnel optimization, health equity, and why betting on fully home-based testing is a bold but necessary move for the future of healthcare. Tune in and learn how at-home diagnostics could fundamentally change how care is delivered and experienced! Resources: Connect with and follow Michael Dubrovsky on LinkedIn. Follow SiPhox Health on LinkedIn and visit their website! Listen to Michael's podcast on Apple Podcasts or Spotify. Email Michael directly here.

How do veterinary diagnostics and education combine to advance veterinary medicine? Tails From the Lab podcast host Dr. Holly Brown sits down to discuss clinical education, diagnostics, and more with Dr. Jimmy Barr (DVM, DACVECC), Chief Medical Officer at Antech™ and Mars Science & Diagnostics, and Dr. Michelle Evason (BSc, DVM, DACVIM, MRCVS), Director of Veterinary Education & Outreach at Antech. Antech & VETgirl are transforming veterinary care through innovative educational programs, like the annual VETgirl certificate series, designed to empower veterinarians, technicians, nurses and teams with practical, pet-first, options-based education. From dentistry to contextualized diagnostics and imaging to infectious diseases, this program includes timely information to advance your preventive care practice. Tune in to hear insights on the upcoming 2026 program, the importance of contextualized diagnostics, and how Antech's initiatives are shaping the future of veterinary practice—all while making complex science accessible and actionable for those on the front lines of animal health. Interested in the 2026 VETgirl Preventive Care Certificate? Earn this certificate for free until 12/31/26, complimentary from Antech. Tails from the Lab is a production of Antech Diagnostics™. The intent of this podcast is to provide education and guidance with the understanding that any diagnostic testing and treatment decisions are ultimately at the discretion of the attending veterinarian within the established veterinarian-patient-client relationship.

How do you go from managing a gym to managing trauma cases in the Operating Room?In this episode, we sit down with Roo Cotter, a former personal trainer who made the incredible leap into the high-stakes world of medical device sales. Roo shares her journey of getting recruited by a gym member to work for Stryker Trauma, navigating the chaos of 14-hour days in the O.R., and her recent pivot into the innovative field of cancer diagnostics with Exact Sciences.If you are an athlete, a trainer, or someone looking to break into medical sales but don't know where to start, this conversation is for you. Roo breaks down how she used grit, networking, and the Medical Sales U program to land her dream job in under two months.IN THIS EPISODE, YOU WILL LEARN:- The unlikely path: How working hard at a gym led to a "lucky" break in MedTech.- The reality of Trauma: What it's really like to be on call 24/7 (and why it teaches you resilience).- Ortho vs. Diagnostics: Why Roo transitioned from the "meathead" world of orthopedics to early cancer detection.- Networking Hacks: How to get internal referrals and skip the "ghosting" phase of job applications.- Mental Toughness: Balancing a high-pressure career with the "1000 Hours Outside" challenge.CHAPTERS:0:00 - Intro: From Personal Trainer to the O.R. 1:55 - Why a Finance Major chose Fitness2:45 - Building relationships with doctors at the gym5:40 - Getting scouted: The Story of landing the Stryker job8:37 - The harsh reality of Trauma Sales (and 14-hour days)13:25 - Transitioning to Neuromodulation (Nalu Medical)16:00 - The Pivot to Diagnostics: Joining Exact Sciences19:15 - How Medical Sales U helped speed up the process24:00 - Avoiding Burnout: The "1000 Hours Outside" ChallengeREADY TO BREAK INTO MEDICAL SALES? If you want to fast-track your career like Roo did, check out our program. We help professionals transition into top-tier medical sales roles: medicalsalesu.com/About the Guest: Roo Cotter is a Medical Sales Professional with experience in Trauma, Neuromodulation, and Diagnostics. A Miami University graduate, she combines her background in finance and fitness to bring a unique, disciplined approach to the O.R.#MedicalSales #Stryker #CareerPivot #PersonalTrainer #MedicalDeviceSales #ExactSciences #SalesCoaching #CareerAdvice #OrthoDisclaimer: The views expressed in this video are those of the participants and do not necessarily reflect the official policy or position of any other agency, organization, employer, or company.

Get a first look at Antech's VMX 2026 education program — built around the realities of clinical practice and the growing need to apply contextualized diagnostics . Join Dr. Michelle Evason (BSc, DVM, DACVIM, MRCVS), Director of Education & Outreach at Antech, and Tammi Lesser, LVT, Regional President, Mars Science & Diagnostics, North America for a behind-the-scenes preview of this year's key themes, including preventive care, case-based learning, and what's new in diagnostic innovation. You'll hear how topics like GI parasite testing, vector-borne disease, and imaging are being brought to life through practical case examples. Plus, gain insight into how veterinary teams can better connect diagnostics to decision-making, communication, and everyday workflow. Tails from the Lab is a production of Antech Diagnostics. The intent of this podcast is to provide education and guidance with the understanding that any diagnostic testing and treatment decisions are ultimately at the discretion of the attending veterinarian within the established veterinarian-patient-client relationship.Just a quick note before we jump into today's episode. Our guests today are Tammi Lesser and Michelle Evason who are employed by Antech. We're sharing this so you have full transparency about the relationships involved.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/MDY865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until December 13, 2026.Implementing Innovation in Alzheimer's Care: Practical Approaches to Adopting New Diagnostics and Disease-Modifying Treatments In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss direct-to-consumer testing. Then, Dr. Pritt welcomes Matthew Binnicker, Ph.D., a microbiologist and virologist and chief scientific officer of Mayo Clinic Laboratories, for a conversation about accelerating innovation without compromising quality or safety. Direct-to-consumer testing (00:38): Explore the rise of direct-to-consumer testing and the challenges that accompany it. Evolving expectations for innovation (05:38): Understand why patient and clinician expectations are rising and how that is reshaping diagnostics.Safeguarding advances (07:23): Learn the foundational principles that protect quality and safety amid rapid innovation.Strategies for accelerating innovation (10:33): Discover practical ways to responsibly deliver novel solutions more quickly.Note: Information in this post was accurate at the time of its posting.ResourcesFive ways to move faster without compromising trust in diagnostics"Answers From the Lab” podcast: Breakthroughs and Trends That Defined Lab Medicine in 2025360Dx: 2025 highlights and takeaways for the clinical lab industry

Most sales teams don't struggle from lack of leads. They struggle from a lack of qualified leads. In this episode of the CEO Sales Strategies Podcast, Doug C. Brown speaks with Maeve Ferguson—founder of The Client Engine™—about how score-based diagnostics and AI segmentation are revolutionizing the way we qualify B2B buyers. Whether you're leading an enterprise sales team or scaling a high-ticket consulting offer, this episode will help you: ✅ Understand why forms and funnels fail to qualify ✅ Use diagnostics to separate low vs. high-intent buyers ✅ Align sales and marketing on what a real lead looks like ✅ Increase revenue per rep by improving qualification

About Michael Dubrovsky:Michael Dubrovsky is a founder-operator and applied scientist working at the intersection of materials science, photonics, and real-world impact. He is the co-founder and CEO of SiPhox Health, a Y Combinator (S20), Khosla Ventures, and Intel Capital–backed startup based in Cambridge, building painless at-home blood biomarker testing to help people live healthier, longer lives. Alongside SiPhox, he serves on the Clinical and Laboratory Standards Institute (CLSI) ILA20 committee and co-hosts 632nm, a technical interview series featuring top scientists and engineers. Previously, he co-founded PoWx, a nonprofit advancing energy-efficient photonic hardware for proof-of-work cryptography, work that is now used commercially to secure billions of dollars in value. Earlier in his career, Michael founded Simply Grid, named by Fast Company as one of the world's most innovative energy companies, deploying first-of-its-kind curbside EV and food-vendor charging infrastructure in New York City before exiting via acquisition. His background includes advanced research at MIT and Technion in nanofabrication and materials characterization and a BS in Chemistry from SUNY ESF. His personal mantra: no hurry, no pause.Things You'll Learn:At-home blood testing eliminates major barriers, such as appointments, referrals, and travel, while expanding access to advanced diagnostics. This convenience is driving higher adoption among both consumers and businesses.Many critical biomarkers linked to longevity and chronic disease are often ignored in standard primary care testing. Home testing allows patients to proactively monitor what would otherwise go unseen.Clinician trust remains a challenge due to early inaccuracies in home testing technologies. FDA clearance is expected to play a major role in broader medical acceptanceBusinesses benefit from home testing by eliminating high-friction steps that stall patient conversion. This leads to better experiences and significantly improved funnel performance.Scaling home diagnostics follows a familiar pattern where early adopters subsidize innovation. Over time, costs drop and access expands to broader populations.Resources:Connect with and follow Michael Dubrovsky on LinkedIn.Follow SiPhox Health on LinkedIn and visit their website.Listen to Michael's podcast on Apple Podcasts or Spotify.Email Michael directly here.

Like the show? Show your support by using our sponsors. Promotive can help you find your dream job. Touch HERE to see open jobs. Need to update your shop systems and software? Try Tekmetric HERERegister NOW for Tekmetric's Tektonic Conference coming up HEREIn this episode, Jeff Compton sits down with Bob Leonard from Mobility Works to delve into the specialized world of vehicle modifications for people with physical disabilities. Bob shares insights into the unique regulatory landscape and technical requirements affecting mobility vehicle conversions, including the importance of following strict certification rules and working closely with certified evaluators. The conversation highlights the technician shortage in the mobility industry, the blend of mechanical and electrical skills required, and the impactful difference these vehicles make in the lives of customers.Timestamps: 00:00 Introduction to The Jaded Mechanic 00:40 Live at ASTA 2025: Meet Bob Leonard from Mobility Works 01:59 What is Mobility Works? The Mission and Services Explained 03:13 Types of Modifications: Minivans, Hand Controls, and High-Tech Installs 05:58 Certification and Audit Processes in Mobility Vehicle Service 08:46 Repairing or Correcting Others' Work: Challenges in Mobility Vehicle Service 11:22 Prescriptions, Regulations & Working with Certified Evaluators 14:19 How Modifications Affect Standard Vehicle Repairs 16:35 Diagnosing Issues When Factory Systems and Modified Controls Meet 19:06 Adapting to EVs and Hybrids in the Mobility Industry 22:04 The Human Side: Fittings, Customer Stories & Building Trust 25:48 Technician Shortages & The Specialized Skills Required 29:08 Training, Following Procedures, and the Role of Inspections 32:38 Troubleshooting Wiring, Diagnostics, and Common Mistakes 36:58 Customer Impact: Independence, Freedom, and Lasting Relationships 41:12 Insurance, Rentals, and the Cost of Mobility Vehicle Ownership 45:42 Body Shop Challenges: Repairs, Estimating, and Crash-Tested Parts 51:02 Advice for Technicians: Approach, Caution, and Knowing When to Call Experts 54:59 The Growing Mobility Market & Emerging Trends 57:01 Life-Changing Mobility Solutions: Why This Work Matters 01:02:57 Wrap-Up: Spreading Awareness & Educating Technicians Follow/Subscribe to the show on social media! TikTok - https://www.tiktok.com/@jeffcompton7YouTube - https://www.youtube.com/@TheJadedMechanicFacebook - https://www.facebook.com/profile.php?id=100091347564232

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Accessible diagnostics isn't a luxury anymore; it's the missing link preventing millions from receiving timely care. In this episode, James York, Chief Commercial Officer and Head of Government Affairs for Molecular Testing Labs, discusses how reimagining the patient journey can remove the economic, geographic, and emotional barriers that keep people from getting essential tests. He explains how at-home self-collection, transparent pricing, and frictionless access are transforming diagnostics, especially for conditions like HIV, STIs, chronic disease markers, and wellness indicators. James walks through the challenges of pioneering new models in healthcare, including regulatory hurdles, industry resistance, and the realities of scaling without major outside funding. He also explains why affordability is inseparable from access, how virtual care has shifted expectations, and why focusing on everyday tests, not cutting-edge technology, is where the greatest impact lies. Tune in and learn how simplifying diagnostics can unlock a more equitable, consumer-centered healthcare system! Resources Connect with and follow James York on LinkedIn. Follow Molecular Testing Labs on LinkedIn and visit their website!

Service Advisors Refusing Walkarounds? Scheduling Chaos? Customers Who Can't Afford Repairs? In this episode of Service Drive Revolution, Chris Collins answers real, unfiltered questions straight from the service drive. From why advisors resist walkarounds, to how to properly schedule service appointments, to what to do when customers can't afford diagnosed repairs, this episode is packed with practical leadership insight and real-world systems thinking. 

Send me a question or story!Periocular dermatitis can occur for a multitude of reasons. The first step is to figure out if the eye itself is involved or not. Once we know the eye is healthy, it is time to figure out why the SKIN AROUND the eye is losing hair, crusty, itchy, etc.It is important to return to the basic diagnostics. Cytology can be sampled with tape (if the lesion is dry) or swab (if the lesion is wet) to not risk damaging the eye. A trichogram can be used instead of a skin scrape to also protect the eye from a scalpel blade!Anything that can cause folliculitis to other areas of the skin can impact the periocular dermatitis. Allergies, mites, dermatophytosis, pyoderma, yeast dermatitis, autoimmune diseases and neoplasia can cause lesions. Dive into the details on this week's episode of The Derm Vet podcast!Timestamps00:00 Intro03:00 Periocular Dermatitis05:21 Cytology Techniques06:45 Allergies and Facial Pruritus08:20 Demodex12:00 Biopsy13:20 Neoplasia16:00 Outro

Behzad Najafian, MD, Professor, Department of Laboratory Medicine & Pathology, Department of Medicine at the University of Washington, Washington, USA discusses the use of artificial intelligence in identifying and managing lysosomal disorders.This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.To obtain CME/CE credit, visit https://checkrare.com/learning/p-grids2025-session1-ai-in-medicine-transforming-the-landscape-of-tissue-based-diagnostics/Learning ObjectivesDescribe recent advances in the applications of AI in lysosomal disorder diagnosis and its clinical relevanceFacultyBehzad Najafian, MD Professor, Department of Laboratory Medicine & Pathology, Department of Medicine, University of WashingtonDisclosuresAffinityCE staff, LDRTC staff, planners, and reviewers, have no relevant financial relationships with ineligible companies to disclose. Faculty disclosures, listed below, will also be disclosed at the beginning of the Program.Behzad Najafian, MDDr. Najafian is on the Advisory Board/Consultant for Sanofi, Amicus, Avrobio, 4DMT,Sangamo, Freeline, AceLink, Relay, CRISPR, ELOXX, SPARK, UNIQURE. He receives grants/research support from Amicus. Mitigation of Relevant Financial RelationshipsAffinityCE adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Conflicts of interest for presenting faculty with relevant financial interests were resolved through peer review of content by a non-conflicted reviewer.Accreditation and Credit DesignationPhysiciansThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Physician AssistantsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.NursesAffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). This activity provides a maximum of 1 hours of continuing nursing education credit.Nurse PractitionersAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.Genetic CounselorsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Genetic Counselors should claim only the credit commensurate with the extent of their participation in the activity.Other ProfessionalsAll other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity. Participation CostsThere is no cost to participate in this activity.CME InquiriesFor all CME policy-related inquiries, please contact us at ce@affinityced.comSend customer support requests to cds_support+ldrtc@affinityced.com

Breakthrough science has never been stronger — yet patients still miss life-saving therapies.Despite decades of innovation, most precision medicines fail at the last mile of healthcare delivery.The problem isn't discovery. It's how science, capital, and systems are aligned — or not.Possessing elite science is no longer enough to win in the multi-trillion-dollar biopharma ecosystem.As innovation shifts from West to East and from treatment to prevention, leadership teams struggle to bridge scientific depth with incentives, execution, and real-world delivery. Capital follows speed and scale — not intention — and healthcare systems built decades ago are failing to keep up.In this episode, Alasdair Milton, Principal at KPMG, explains where innovation actually breaks — and what must change for cures to reach patients at scale. From diagnostics and data silos to capital allocation and prevention models, this conversation reframes the next decade of precision medicine.

A liquid biopsy is a blood test that detects signs of cancerous tumors, including tumour cells and cancer cell DNA. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Andrew Newland, CEO of ANGLE, about why live cell liquid biopsies should become standard in oncology. Newland explains how current US FDA-approved tests can detect some types of advanced cancers, predict prognosis, and help healthcare providers make treatment decisions. And importantly, Newland describes how live cell liquid biopsies are a UK-developed technology that aligns with national efforts to modernise cancer diagnostics, as well as potentially reduce healthcare costs by minimising ineffective treatments. You can listen to episode 238 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

As part of our official DealFlow Discovery Conference Interview Series, produced by Mission Matters, along with our partner DealFlow Events, we're showcasing the innovative companies presenting at the DealFlow Discovery Conference and the executives behind them. ---- In this episode, Adam Torres interviews Ilan Danieli, CEO of Precipio, about the company's mission to reduce cancer misdiagnosis—especially in complex blood-related cancers. Ilan explains how Precipio partners with academic experts to expand access to subspecialty pathology, why accuracy matters more than speed, and how better diagnostics can directly change treatment decisions and patient outcomes. About Ilan Danieli Ilan Danieli has served as Precipio's CEO since founding the company in early 2011. With over 20 years managing small and medium-size companies, some of his previous experiences include COO of Osiris, a publicly-traded company based in New York City with operations in the US, Canada, Europe; Laurus Capital Management, a multi-billion dollar hedge fund; and in various other entrepreneurial ventures. Ilan holds an MBA from the Darden School at the University of Virginia, and a BA in Economics from Bar-Ilan University in Israel. Ilan has a private pilot license, plays the saxophone, and possesses infinite love for his horses. About Precipio Precipio's platform delivers superior diagnostic accuracy through academic expertise and cutting edge technology. They are a laboratory focused on delivering specialized diagnostic services to physicians and their patients to ensure they receive accurate results. Watch Full Episode on ⁠Youtube⁠. --- This interview is part of our effort to help investors discover compelling companies ahead of the event — and to help CEOs introduce their story to the 1500+ conference attendees. Learn more about the event and presenting companies: ⁠⁠https://dealflowdiscoveryconference.com/⁠ Follow Adam on Instagram at ⁠https://www.instagram.com/askadamtorres/⁠ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: ⁠https://missionmatters.lpages.co/podcastguest/⁠ Visit our website: ⁠https://missionmatters.com/⁠ More FREE content from Mission Matters here: ⁠https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

Start making $150k - $200k+ in your first year of medical sales. Stop chasing crowded "old school" roles like Orthopedics and Spine. The real money—and the life-saving innovation—is in Oncology and Specialty Pharma. Today, I reveal the exact blueprint to reinvent your career and break into the most lucrative sector of healthcare. Whether you're a nurse, a teacher, or stuck in a "middle-class mindset," this episode breaks down why your background doesn't matter. Only your preparation does.I share my personal journey from a non-profit minister making $70k to a high-level oncology rep, and explain why "casual advice" from friends will get you rejected. If you want to master the interview, crush your clinical knowledge, and build a 6-figure life, this is the masterclass you need.WHAT YOU WILL LEARN IN THIS EPISODE:- The "Gold Rush" Shift: Why you should ignore Orthopedics and focus entirely on Oncology, Diagnostics, and Genetic Testing.- The 3 Essential Mindset Shifts: How to move from "winging it" to becoming an obsessively prepared candidate.- Real Success Stories: How Kanika (immigrant to Dallas), Sydney (nurse), and others went from zero experience to $200k roles.- The "Ride-Along" Trap: Why you need a brutal coach, not a nice mentor.- The HEART Framework: The 5 character traits (Humility, Energy, Active Listening, Resilience, Trust) that hiring managers look for.- Confidence vs. Arrogance: How to show "grit" without sounding like a jerk.- Daily Habits of Top 1% Earners: The 5 AM club, the "20 LinkedIn adds" rule, and why your degree (MBA) has a lower ROI than coaching.- The Michael Jordan Rule: Why even the greatest of all time hired coaches for their specific weaknesses.TIMESTAMPS00:00 - Introduction: The Program Focus (Oncology vs. Orthopedics)01:34 - Dave's Story: Reinventing Career from Ministry to Medical Sales03:44 - Success Stories: How Nurses & Immigrants Got Hired (Kanika, Sydney)06:47 - Mindset Shift #1: Be Coachable (Why Friends Can't Help You)09:20 - Mastering Virtual Interviews (Lighting, Camera & Background)10:32 - Mindset Shift #2: Be Curious (Understanding Clinical Trials & FDA)12:32 - Salary Reality: Device Associate ($80k) vs. Oncology ($155k+)13:55 - Mindset Shift #3: Collaboration (Working with MSLs & Nurse Navigators)16:28 - Confidence vs. Arrogance (The "Grit" Trap)18:02 - The H.E.A.R.T. Framework (Humility, Energy, Listening, Resilience, Trust)19:00 - Daily Habits: 5 AM Wake-ups, LinkedIn Strategy & Handling Rejection20:00 - The"Middle Class Mindset" Trap: Why Degrees Have Low ROI22:25 - Using AI for Resumes Without Sounding Like a Robot25:55 - The "Why": Patient Outcomes & Life-Extending Impact29:35 - The 3 Questions You Must Ask Yourself31:01 - The Michael Jordan Analogy: Why Even the Best Hire Coaches.ABOUT MEDICAL SALES U: Medical Sales U is the premier training program for professionals looking to break into high-paying careers in Medical Device, Pharmaceutical, and Genetic Testing sales. We turn "outsiders" into top 1% candidates.CONNECT WITH US: Learn more about coaching and career support at medicalsalesu.com/#MedicalSales #OncologySales #CareerPivot #SalesCoaching #HighIncomeSkills #DaveSterrett #MedicalSalesYou #InterviewTips #SalesJobs #PharmaceuticalSales

In this episode, Sam Ashoo, MD and T.R. Eckler, MD discuss the December 2025 Emergency Medicine Practice article, Diagnosis and Management of Cannabis-Related EmergenciesEpisode Outline: [0:00] IntroductionWelcome and show overview by Sam AshooMention of resources at ebmedicine.net[0:46] Episode StartHosts introduce themselves: Sam Ashoo and Dr. T.R. EcklerDr. Eckler's background and experience with cannabis cases in Colorado[1:16] Topic IntroductionFocus on diagnosis and management of cannabis-related emergenciesPrevalence and importance in emergency medicine[1:34] Legal LandscapeOverview of cannabis legality across statesMedicinal vs. non-medicinal use[3:03] Increase in ED VisitsStatistics: ~1 million cannabis-related ED visits annuallyDemographics: younger population most affected[3:52] Synthetics and ChallengesDiscussion of synthetic cannabinoids and their risksIssues with detection and legality[4:50] Clinical SpectrumRange of presentations: from nausea/vomiting to psychosis and seizuresImpact on different age groups[6:34] FDA-Approved UsesCannabis-derived products approved for specific medical conditions[7:20] Physiology and PathophysiologyCannabinoid receptors (CB1 and CB2) and their effectsDifferences between plant-derived and synthetic cannabinoids[9:10] Chronic Use and WithdrawalDownregulation of receptors, withdrawal symptoms, and persistent nausea[10:20] Product Forms and Delivery MethodsSmoking, edibles, oils, tinctures, suppositories, topicals, etc.Risks associated with concentrated forms (e.g., wax, oils)[12:00] Clinical Effects by SystemPsychiatric: anxiety, psychosis, paranoiaCardiovascular: tachycardia, MI risk, QT prolongationPulmonary, renal, metabolic, dental, and ocular effects[13:50] Cannabinoid Hyperemesis Syndrome (CHS)Phases: prodrome, hyperemesis, recoveryHot showers as a diagnostic clue[16:00] Withdrawal SyndromeSymptoms and timelineExacerbation with synthetic cannabinoids[18:15] Counseling and ManagementImportance of cessation and patient educationTimeline for symptom improvement[18:42] Differential DiagnosisBroad differential for persistent nausea/vomiting and abdominal painImportance of considering other causes[20:55] Diagnostics and TestingLimitations of drug screens (false positives/negatives)Importance of EKG, labs, and imaging as indicated[23:10] Treatment ApproachesFirst-line: benzodiazepines, antiemetics (ondansetron, metoclopramide)Second-line: butyrophenones (haloperidol, droperidol), olanzapineCapsaicin as adjunct therapy[29:50] Complications and Special ConsiderationsRisks of undertreatment (e.g., Boerhaave syndrome, aspiration)Pediatric and pregnant populations: unique risks and reporting requirements[36:00] Five Practice-Changing TakeawaysElicit cannabis use historyKnow testing limitationsConsider ECG and appropriate labsUse butyrophenones when indicatedAdmit if symptoms are refractory[39:00] ConclusionEmergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net

Graham Rigby is the President and CEO of the American Herbal Products Association (AHPA), the leading trade association for the herbal products industry. With 20 years of experience across startups and industry leadership—including serving as Chief Innovation Officer at Care/of—Graham has helped shape how modern supplement brands navigate regulation, formulation, and go-to-market strategy.In this episode of DTC Pod, Graham shares what it actually takes to launch and scale a supplement brand without getting burned by regulators. He breaks down exactly where the line is between claims that sell and claims that get you in trouble, why so many founders get blindsided by FDA and FTC enforcement, and how to work with contract manufacturers when you're just starting out. Graham also gets into the real opportunity in supplements right now—why clinical trials cost 90% less than they did two decades ago, how AI is changing the formulation game, and why a $70 billion market growing at 6.5% still has plenty of room for new entrants. Plus, his take on the brands that are doing it right, from AG1 to Ritual, and what founders can learn from their playbooks.Episode brought to you by StordInteract with other DTC experts and access our monthly fireside chats with industry leaders on DTC Pod Slack.On this episode of DTC Pod, we cover:1. The evolution and growth of the herbal supplement industry2. Key regulatory milestones: DSHEA, GMPs, and FDA compliance for supplements3. What founders must do to stay compliant when launching a supplement brand4. The distinction between pharmaceuticals, dietary supplements, and nutraceuticals5. Marketing, claims, and the importance of substantiation6. Emerging opportunities with clinical trials and claim innovation7. DTC, Amazon, TikTok, and brick-and-mortar distribution channels for wellness brands8. The practicalities and risks of supplement retail (and when to scale beyond DTC)9. Practitioner and non-traditional channels for supplement sales10. How Ingredient AI, Infinite Garden, and other platforms are applying AI to supplements11. Content creators, credentialed doctors, and the new face of trusted health advice12. The role of diagnostics, wearables, and personalization in driving supplement trends13. Growth outlook: Why the supplement market is just getting startedTimestamps00:00 Intro to DTC POD and Graham Rigby02:25 20 years of supplements: Startup vs. regulatory side03:00 The exponential growth of the herbal products market04:44 Regulatory basics: DSHEA, FDA oversight, and GMPs explained07:14 How AHPA helps brands navigate compliance and education08:03 Launching a supplement brand: Key compliance steps and best practices10:00 FDA's post-market regulatory process and founder responsibilities13:04 Supplements vs. pharmaceuticals: Safety, claims, and approvals17:32 Telling stories and using clinical research for marketing claims20:00 What marketers can and cannot say: Health vs. disease claims22:04 Substantiating claims and the importance of compliance for growth24:31 Label vs. online claims: How rules apply to different channels27:02 DTC vs. Amazon, TikTok, and expanding to retail and practitioner channels30:19 The risks and rewards of brick-and-mortar expansion35:14 AI and technology's role in supplement industry efficiency and safety40:47 The rise of content creators and doctors shaping supplement education46:34 Diagnostics, wearables, and the future of personalized wellness51:13 Supplement industry outlook and advice for emerging brands52:25 How to connect with Graham and AHPA, and upcoming founder programsShow notes powered by CastmagicPast guests & brands on DTC Pod include Gilt, PopSugar, Glossier, MadeIN, Prose, Bala, P.volve, Ritual, Bite, Oura, Levels, General Mills, Mid Day Squares, Prose, Arrae, Olipop, Ghia, Rosaluna, Form, Uncle Studios & many more.  Additional episodes you might like:• #175 Ariel Vaisbort - How OLIPOP Runs Influencer, Community, & Affiliate Growth• #184 Jake Karls, Midday Squares - Turning Your Brand Into The Influencer With Content• #205 Kasey Stewart: Suckerz- - Powering Your Launch With 300 Million Organic Views• #219 JT Barnett: The TikTok Masterclass For Brands• #223 Lauren Kleinman: The PR & Affiliate Marketing Playbook• ​​​​#243 Kian Golzari - Source & Develop Products Like The World's Best Brands-----Have any questions about the show or topics you'd like us to explore further?Shoot us a DM; we'd love to hear from you.Want the weekly TL;DR of tips delivered to your mailbox?Check out our newsletter here.Projects the DTC Pod team is working on:DTCetc - all our favorite brands on the internetOlivea - the extra virgin olive oil & hydroxytyrosol supplementCastmagic - AI Workspace for ContentFollow us for content, clips, giveaways, & updates!DTCPod InstagramDTCPod TwitterDTCPod TikTokGraham Rigby - President & CEO of American Herbal Products Association (AHPA)Blaine Bolus - Co-Founder of CastmagicRamon Berrios - Co-Founder of Castmagic

When growth stalls, it's time to get personal.  Ever felt like you've done all the "right" things in your business, but your results don't add up? You're not alone. In this episode of Your Passion, Purpose, and Personal Brand, host Lisa McGuire sits down with business strategist Maeve Ferguson to challenge everything we've been told about marketing funnels, freebies, and formulas. They explore the quiet revolution happening behind the scenes that few people know about yet. It's one driven by data, dignity, and diagnostics. This is not another pep talk. This is a call to alignment. You'll learn why personalization is the new currency in business, how traditional funnels are quietly failing, and what it really takes to attract high-level clients without selling your soul (or your calendar) to outdated discovery calls. Maeve reveals how entrepreneurs are collapsing months of guesswork into clarity by transforming their intellectual property into score-based diagnostics that do more than convert. They connect. If you've ever whispered to yourself, "I know I'm meant for more...but I don't know where I lost the map," this conversation is your compass. KEY TAKEAWAYS Traditional funnels are outdated. Today's audiences crave personalization. Diagnostic assessments segment leads for higher precision and conversions. Mass emails and checklist freebies often repel rather than attract. Your audience's sophistication has evolved. It's time your strategy does too. Diagnostics let you identify who's truly ready and willing to buy. Rich niche positioning attracts elevated clients and filters out misaligned ones. Mapping your IP (yes, you have it) gives clarity, confidence, and authority. AI and mediocrity are flooding the market. Your differentiation is being real. When you stop chasing and start aligning, sales become symphonic. Success is not about "doing more." It's about becoming more of who you are.   CONNECT WITH MAEVE LinkedIn Profile: https://www.linkedin.com/in/maeveferguson/ Instagram Profile: https://www.instagram.com/iammaeveferguson/ Website: www.maeveferguson.com  CHECK OUT MAEVE'S FREE RESOURCE: https://www.impactscoreassessment.com   CONNECT WITH LISA Beyond the Transaction Mastermind -  Apply to join the group: https://beyondthetransactionmm.com/register Sign up for Lisa's "so much more" newsletter: https://www.thediyframework.com/so-much-more-subscribe  Freedom Reset: Your Next Steps to Realignment  Register: https://go.lisamcguire.com/freedom-reset  Human Design Masterclass Waitlist: https://go.lisamcguire.com/human-design-masterclass-waitlist  Ideal Client Workshop Waitlist: https://go.lisamcguire.com/ideal-client-workshop-waitlist-icww785155  Get your free Human Design Bodygraph: https://lisamcguire.com/get-your-free-chart/   

Mike Nemer interviewed Kevin Carriere, the CEO of Powertron Global, who explained that he entered the HVAC industry after meeting engineers developing solutions for heat exchanger efficiency restoration. On episode 310 of The Green Insider podcast, Kevin described how Powertron Global was founded to address HVAC efficiency issues, expanding beyond initial heat exchanger solutions to tackle other efficiency-robbing factors in climate control systems. Todays podcast includes: Sustainable HVAC Efficiency Restoration Sustainable HVAC practices can lead to cost savings, not just environmental benefits. HVAC systems lose efficiency over time, mainly due to heat exchanger capacity loss, which increases energy use and maintenance. Powertron engineers developed a heat exchanger restoration technology to restore lost efficiency, filling a gap in the industry. Craftsmanship and education on efficiency restoration are crucial, especially for city and government agencies. HVAC Efficiency Diagnostics Platform Most HVAC systems, especially in taxpayer-funded facilities, operate 30–40% below their intended design capacity. Powertron created a proprietary forensic measurement and verification platform, collecting data from over 400 studies in 38 countries. The company focuses on restoring system capacity and providing diagnostic data to manufacturers and researchers, serving clients like cell tower huts, convenience stores, and government facilities. HVAC Efficiency Loss Over Time New HVAC systems lose 5–7% efficiency in the first year (with proper maintenance), then 3–4% annually, reaching a 25–30% reduction over time. Systems in regions with long cooling seasons (eastern/western US) can lose significant efficiency in 3.5–5 years; in the Midwest, it takes about twice as long. Rooftop units expected to last 15 years are often replaced in 10 due to efficiency loss and increased runtime. Type System ROI and Sustainability The ROI for Powertron's type system is typically 12–18 months, but as short as 3 months for mission-critical sites (e.g., data centers, hospitals). The goal is to restore systems to their design capacity, improving efficiency and generating further savings. Certified reports are provided to quantify emissions reductions and energy savings, which can be used in customers' sustainability reports. To be an Insider Please subscribe to The Green Insider powered by ERENEWABLE wherever you get your podcast from and remember to leave us a five-star rating. This podcast is sponsored by UTSI International. To learn more about our sponsor or ask about being a sponsor, contact ERENEWABLE and the Green Insider Podcast. The post Maximizing HVAC Efficiency: Sustainable Restoration, Diagnostics, and ROI appeared first on eRENEWABLE.

Health care executive Kevin King discusses his article, "How to stay safe from back-to-school illnesses." Kevin explains why the return to classrooms often triggers a surge in respiratory illnesses (like the flu, COVID-19, and RSV) and how diagnostic tests are a critical tool for managing them. He highlights how rapid diagnostics are essential for getting the right treatment quickly, such as antivirals, and perhaps more importantly, for preventing the wrong treatment, which helps combat the growing threat of antibiotic resistance. Kevin also offers insight into how epidemiologists predict outbreaks by monitoring school absenteeism and data from the Southern Hemisphere, providing a fascinating look at community health surveillance. Discover how early and accurate testing serves as our frontline defense in protecting vulnerable populations and managing respiratory illnesses this school season. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

We are in our 3rd week of our 4-part series on the #1 killer in America.   And we're talking about the Diagnostics that Dr. Prather uses to get to the root cause of Cardiovascular Disease. In this episode, you'll learn:—How Diagnostics are "even more important and more complete" in the Structure-Function Health Care model than in Disease Care.—Why the electrical system of the Heart is so important.   And how Dr. Prather uses what he considers "the best" in Holter monitors to measure a patient's electrical system.—The way a patient's EKG will completely normalize though the therapeutic exercise External CounterPulsation (ECP) Therapy at Holistic Integration .—The impact of the Nervous System on the Heart's electrical system, which can be improved through Chiropractic care.  And the way Holistic Integration measures the Vagus Nerve and the Parasympathetic and Sympathetic balance through their Autonomic Nervous System (ANS) Test. —Why Minerals are "critical" to the electrical system of the Heart.  And how Minerals are best measured through Hair Analysis and Bloodwork. —The amazing story of the patient whose WATCH was throwing off his heart's electrical system. —How Dr. Prather sees many Heart problems cleared up by clearing Heavy Metals out of people.—Why getting to the root cause of a patient's Heart problem is "like detective work". —The link between infections and Cardiovascular Disease, such as the Coxsackie B virus which can cause Cardiomyopathy.  And how infections, most commonly Strep, can also cause Heart Valve Issues.—How the Heart CAN be healed and has an amazing ability to regenerate.http://www.TheVoiceOfHealthRadio.com*Receive exclusive bonus content as a member of our Voice Of Health Patreon Community:https://www.patreon.com/cw/VoiceofHealthPodcast

his podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com A fingertip-sized blood sample may soon replace the needle stick millions of patients avoid every year. In this episode, Web Golinkin, President of Babson Diagnostics, shares how Better Way, a fingertip blood collection system, is redefining convenience, accuracy, and accessibility in diagnostic testing. He explains how the company spent nearly a decade validating its technology through 45+ IRB-approved studies, 4,300+ participants, and more than 850,000 tests to ensure clinical equivalence to venous draws. He traces the innovation's journey from a Siemens skunkworks project to partnerships with BD and a 510(k)-cleared device, culminating in an 80% primary-care test menu from a pea-sized sample. He also highlights how Better Way improves adherence, enhances patient and staff experience, and reduces friction with clear, graphical results. Tune in and discover how fingertip testing can transform preventive care, patient engagement, and healthcare operations! Resources Connect with and follow Web Golinkin on LinkedIn. Follow Babson Diagnostics on LinkedIn and visit their website!

Anne Zink is a lecturer and senior fellow at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.B. Zink, N.C. McCann, and R.P. Walensky. From Crisis to Action — Policy Pathways to Reverse the Rise in Congenital Syphilis. N Engl J Med 2025;393:2388-2391.

Thanks to our Partners, NAPA Auto Care and NAPA TRACS Watch Full Video Episode Eric Svedberg breaks down a smarter, more profitable way to price diagnostic work—what he calls the Level Testing Sales Amplifier. At its core, the system tackles a problem most repair shops quietly accept: testing is often a loss leader. When technicians are tied up diagnosing complex issues, shops miss out on parts sales. A-level technicians can earn less than their B-level counterparts doing routine work, and the rising cost of software and tools goes unpaid. Svedberg reframes the conversation by using the word “testing” instead of “diagnostics,” a term he believes is clearer and more intuitive for customers. Testing implies a process, not a guarantee—setting expectations from the start. The Level Testing system uses a tiered structure tied to the shop's base labor rate: Level One – Basic Testing:Single, constant, duplicable issues (like a check engine light that's always on).Level Two – Intermediate Testing:Multiple concerns or intermittent problems.Level Three – Pandora's Box:Highly complex vehicles, often previously misdiagnosed or unsuccessfully repaired elsewhere.Level Four – “Grandmother Rate”:Disaster cars involving severe electrical damage, corrosion, or major disassembly. While the levels are designed as an internal framework, Svedberg finds transparency with customers increases trust and buy-in. Service advisors are coached to remove Level Three from most conversations upfront, steer customers toward Level Two testing as the norm, and clearly explain that testing fees are for time spent—not credited toward repairs. For true Level Three cases, advisors frame the value honestly: if it were simple, another shop would have already fixed it. Svedberg emphasizes that the system is easy to train and implement—often within a week—by focusing on quick wins with top advisors. Its simplicity improves communication, closes the tech efficiency gap, and can be applied beyond diagnostics to services like module programming and ADAS calibration. Every decision, he says, must pass the test: Is it good for the car? Good for the customer? Good for the shop? Eric Svedberg, European Autowerks, Virginia Beach, VA, https://www.gofuelcoaching.com/ , https://www.europeanautowerks.com/ Thanks to our Partners, NAPA Auto Care and NAPA TRACS Learn more about NAPA Auto Care and the benefits of being part of the NAPA family by visiting https://www.napaonline.com/en/auto-care NAPA TRACS will move your shop into the SMS fast lane with onsite training and six days a week of support and local representation. Find NAPA TRACS on the Web at http://napatracs.com/ Connect with the Podcast: -...

About James York:James York serves as the Chief Commercial Officer and Head of Government Affairs at Molecular Testing Labs, where he leads the company's mission to expand access to diagnostics and transform patient engagement with their health. With over a decade of leadership experience at the organization, James drives commercial strategy, strategic partnerships, business development, and market education, championing a consumer-centric approach to laboratory medicine. His work focuses on advancing transparency, affordability, and proactive health management by ensuring that individuals, regardless of their circumstances or geography, can benefit from timely diagnostic insights. James' career spans executive roles across healthcare, including CEO and president positions, as well as senior leadership in sales and business development, providing him with a deep understanding of both clinical and commercial landscapes. Guided by a commitment to equitable access and meaningful innovation, he continues to influence how advanced diagnostics are delivered and adopted across the healthcare ecosystem.Things You'll Learn:Making diagnostics accessible requires removing economic, geographic, and emotional friction so patients can participate in their own care. At-home self-collection solves barriers that traditional labs cannot.Affordability is inseparable from access, and transparent low-cost testing is critical for supporting large populations who are “functionally uninsured.” Most patients avoid care because they cannot predict the financial burden.Virtual care has accelerated the need for decentralized diagnostics, as patients who seek care online are unlikely to travel to a physical laboratory. Without accessible testing, virtual clinical pathways break.Pioneering new diagnostic models is challenging, costly, and often met with resistance from incumbents and regulators. Yet these challenges highlight the significance of the innovation.The greatest opportunity in diagnostics lies not in high-tech breakthroughs but in improving everyday tests that influence most clinical decisions. Access, not technology, is the true innovation.Resources:Connect with and follow James York on LinkedIn.Follow Molecular Testing Labs on LinkedIn and visit their website. 

Are you trying to break into medical sales but stuck deciding between Pharmaceutical and Medical Device? Or maybe you're curious about the high-growth world of Diagnostics and Genomics?Today, we discuss the differences in pay, lifestyle, and entry-level requirements for each path. Whether you want the adrenaline of the Operating Room or the stability of a $130k+ base salary in Pharma, this episode covers the 12 key distinctions you need to know before applying. IN THIS EPISODE YOU WILL LEARN:The Personality Test: Why "Engineers" love Device and "Scientists" love Pharma.The Paycheck: Real breakdown of base salaries vs. uncapped commissions.The Hidden Third Option: Why Oncology Diagnostics/Genomics might be the "Goldilocks" career path.Work-Life Balance: The reality of on-call surgical hours vs. the 9-to-5 pharma life.Success Stories: How a nurse (Sydney) and an immigrant (Kanika) broke in with $150k-$200k packages.READY TO BREAK IN? If you are struggling to get offers or don't know where to start, we help people from all backgrounds (nurses, coaches, teachers) launch their medical sales careers.Apply to Medical Sales U at medicalsalesu.com/TIMESTAMPS:00:00 - Intro: The common dilemma (O.R. vs. Samples).01:06 - The 3 Paths: Pharma, Device, and Diagnostics.02:15 - Science vs. Engineering: Which fits your brain?04:35 - Salary Reveal: Entry-level Pharma Pay ($95k-$135k base).06:10 - The "Associate" Role: Why Device base pay starts lower.07:40 - The Top 1%: Earning potential ($300k - $750k).09:15 - Diagnostics Pay: The sweet spot?10:30 - The Sales Process: Who are you actually selling to?13:50 - Lifestyle Check: Early mornings vs. Family flexibility.17:15 - Career Advancement: From Rep to Regional Director.22:15 - Student Success: From $68k to $200k total comp.ABOUT MEDICAL SALES U: Medical Sales U is the premier training program for professionals looking to break into high-paying careers in Medical Device, Pharmaceutical, and Genetic Testing sales. We turn "outsiders" into top 1% candidates.CONNECT WITH US:Learn more about coaching and career support at medicalsalesu.com/#MedicalSales #PharmaceuticalSales #MedDevice #SalesCareer #DaveSterritt #CareerAdvice #HighPayingJobs #SalesTips

AABP Executive Director Dr. Fred Gingrich is joined by Dr. Angel Abuelo, AABP member on faculty at Michigan State University College of Veterinary Medicine. Abuelo presented at the 2025 AABP Recent Graduate Conference in Norman, Okla. on managing Salmonella Dublin. AABP members can listen to this presentation for free by accessing the online CE portal on this page or download the BCI Mobile Conference app from your device's store.  Salmonella Dublin is a host-adapted pathogen that results in high morbidity and mortality due to the systemic nature of the disease in calves and in most cases, the pathogen exhibits multi-drug resistance. This pathogen also has implications for human health as a zoonotic disease. Abuelo discusses the clinical presentation in calves is primarily respiratory disease and the carrier state that can be seen in adult cows that serve as a continuous reservoir to maintain the disease on a farm. Diagnostics should include multiple tissues from deceased calves that are necropsied. The best sample to submit in live calves is not feces, but aseptically collected blood cultures.  Abuelo discusses the nuances of treatment in affected calves and due to multi-drug resistance, response to therapy can be poor or lead to a carrier state in recovered animals. Although enrofloxacin is labeled for treatment of bovine respiratory disease, it is not specifically labeled for treatment of Salmonella Dublin and extralabel use of fluoroquinolones in food animals is prohibited by the FDA.  Prevention of the disease is multifactorial and includes all aspects of proper neonatal calf management including adequate and timely pasteurized colostrum, maternity pen management, ventilation, sanitation and nutrition. Abuelo also discusses the use of vaccines in cows and calves to manage the disease on endemically infected farms to prevent outbreaks. Continued research on managing this disease, including the use of vaccines and improved diagnostics, will be important topics for veterinarians and producers who are managing this pathogen. REFERENCES: Frye E, Jennings C, Kremer K. Aseptic technique for blood culture collection in the field to diagnose Salmonella Dublin in calves. J Am Vet Med Assoc. 2025;263(7):1. https://doi.org/10.2460/javma.25.02.0116. PMID: 40267971. https://avmajournals.avma.org/view/journals/javma/263/7/javma.25.02.0116.xml Castro-Vargas RE, Cullens-Nobis FM, Mani R, Roberts JN, Abuelo A. Effect of dry period immunization of Salmonella Dublin latent carriers with a commercial live culture vaccine on intrauterine transmission based on the presence of precolostral antibodies in offspring. J Dairy Sci. 2024;107(12):11436-11445. https://doi.org/10.3168/jds.2024-24945The effect of Salmonella vaccination on Salmonella Dublin blood enzyme-linked immunosorbent assay results. Bov Pract. 2025;59(2), 53-60. https://doi.org/10.21423/bpj20259266 Abuelo A, Renaud D.  Salmonella Dublin Infection in Cattle. Merck Veterinary Manual. 2024. Winter A, Abuelo A, Allen DG, et al. (Eds). Merck, Rahway, NJ, USA. https://www.merckvetmanual.com/digestive-system/salmonellosis/salmonella-dublin-infection-in-cattle Salmonella Dublin Risk Management HERD SD app: https://apps.apple.com/us/app/herd-sd/id6748356498   

In this episode, Eric Malzone sits down with Dr. Ryan Greene, founder and CEO of Monarch Athletic Clubs. Dr. Greene shares his journey from exercise physiology and medical training to creating an all-in-one health club designed for true wellness—not just fitness. They dive into why our healthcare system is really a "sick care" system, how Monarch integrates medicine, personal training, recovery, and community under one roof, and the surprising reason their clubs stayed open during the pandemic. Dr. Greene also opens up about the future of longevity, the problem with having data but no actionable plan, and why mental health and authentic community are the next frontiers in health.

Sponsored by the Institute for Functional Nursing (IFN) www.fxnursing.com In this episode, Brigitte interviews Ryan Obermeier of Evexia Diagnostics to show nurses exactly how to streamline functional lab testing inside a holistic or functional nursing practice. We break down how Evexia centralizes thousands of functional and specialty tests, simplifies ordering, integrates with systems like Practice Better, and reduces the administrative burden that often slows down new and growing practices. Ryan explains Evexia's Internal Physician Network, which supports nurses who need physician authorization for specialty testing, as well as the Ask the Doctor program for clinical interpretation of advanced labs. We also cover Evexia's Functional Health Report, supply management, troubleshooting support, white-label marketing tools, and how nursing using the link below can access exclusive perks, waived fees, and discounted resources. Whether you're launching a functional nursing practice or scaling an established clinic, this episode gives you a clear roadmap for improving efficiency, patient outcomes, and clinical confidence through better lab workflows. What We Cover in This Conversation: • How Evexia centralizes thousands of functional & specialty lab tests • Streamlined ordering, processing, and automated reporting • EHR integration with Practice Better and other platforms • Functional Health Report for blood chemistry interpretation • Internal Physician Network for non-licensed or collaborating providers • Ask the Doctor program for specialty lab interpretation • Reducing hidden costs, operational friction, and admin overwhelm • White-label and marketing tools available through the link below • How nurses can register and access waived fees + bonus support Functional Nurses Offer: Register With Evexia Diagnostics Evexia is extending exclusive benefits for our functional nursing community of RNs and NPs, including waived fees and access to additional support tools. Create your account here: https://www.evexiadiagnostics.com/lp/brigitte-sager-landing-registration-page

About Web Golinkin:Web Golinkin is a seasoned healthcare executive, entrepreneur, and author with more than 35 years of leadership experience, including six CEO roles and three companies he co-founded. Over the last two decades, he has focused on expanding access to affordable, basic healthcare, establishing himself as a pioneer in both retail-based clinics and urgent care. His insights into the evolution of consumer-focused healthcare have been featured in The Wall Street Journal, Forbes, The Today Show, Fox Business, and numerous industry conferences. Web is also the author of Here Be Dragons, published by Forbes Books in 2024. His career spans leadership positions across healthcare delivery, population health management, medical communications, and consumer health media, including his current role as president of Babson Diagnostics and previous leadership at FastMed Urgent Care, Health Dialog, RediClinic, America's Health Network, and American Medical Communications. A graduate of Harvard University, Web continues to shape the future of healthcare through innovation, accessibility, and patient-centered design.Things You'll Learn:Better Way can deliver 67 clinically equivalent tests from a fingertip blood sample, covering more than 80% of common primary care needs. This allows patients to avoid the traditional needle-based blood draw.Nearly a decade of validation, including thousands of study participants and hundreds of thousands of tests, demonstrates the scientific rigor behind the technology. This long research runway enabled FDA clearance and strong clinical confidence.About one-third of patients avoid blood testing due to needle phobia or inconvenience, contributing to major gaps in preventive care. A more straightforward, painless collection method directly addresses this barrier.Health systems can increase patient adherence and reduce reliance on phlebotomists by cross-training staff to use the system within 2.5 hours. This unlocks staffing flexibility and operational efficiency.Better Way focuses on reducing friction across the entire testing journey, including simplified, graphic-rich patient result reports. This empowers patients to understand their health without having to decipher complex medical language.Resources:Connect with and follow Web Golinkin on LinkedIn.Follow Babson Diagnostics on LinkedIn  and visit their website.

Host Dr. Linda Chu speaks with Dr. Jana Ivanidze and Dr. Rajiv Magge about how molecular imaging is transforming the diagnosis and management of breast cancer brain metastases, with an emphasis on precision and personalized care. Their discussion highlights emerging tools such as advanced PET techniques and liquid biopsy that support earlier detection, guide treatment planning, and shape the future of neuro-oncology. Sponsored by GE HealthCare.      

Vrajesh Pandya. Transdermal GFR Signals a New Horizon in Renal Diagnostics. Clinical Chemistry, Volume 71, Issue 12, December 2025, Pages 1281–1282. https://doi.org/10.1093/clinchem/hvaf106

Published Dec. 4, 2025In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and the first reported death from alpha-gal syndrome. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories' chief digital innovation officer and medical director of BioPharma Diagnostics, to explore how biopharma diagnostics advance research and development. PAMA reform update (00:33): Get the latest on where reform to PAMA stands following the federal government's reopening.Alpha-gal syndrome case (03:22): Learn about the first known death from alpha-gal syndrome and diagnostic testing for this tick-bite-triggered red meat allergy.Biopharma's role in research and development (07:52): Discover how biopharma diagnostics fuel innovation and how digital tools are expanding its future impact.  Note: Information in this post was accurate at the time of its posting.ResourcesBioPharma Diagnostics: Connecting pharma and biotechTick-borne disease: An expanding geographic threat

Send us a textIn this episode of Vet Life Reimagined, Dr. Eve Hanks, BVM&S, CertAVP (EM), PhD, FRCVS, takes us inside the emerging world of microRNA diagnostics, a technology that could transform how veterinarians detect and manage disease across species.Dr. Hanks' journey is remarkable: from becoming a single mom at 19, to mixed animal practice, to discovering a passion for research, and ultimately founding MiRNA, a biotech company advancing early-detection diagnostics in animals.Eve explains what microRNAs are, why they represent a major leap forward in precision medicine, and how this technology may allow veterinarians to identify chronic disease earlier and improve outcomes for both companion and production animals. She also shares honest insights about leadership, resilience, and what it really takes to build a mission-driven company from the ground up.This conversation blends science, innovation, and career inspiration — a must-listen for anyone curious about the future of veterinary medicine.Resources:Episode on YouTubeMiRNA websiteMiRNA on LinkedInGet your gift guide here. Support the showMore Vet Life Reimagined?

Con Hermano IsaiasIEPDE.comEsperanzaConJesus.comGloriosoDerramamiento.com

Join us as we sit down with Joey Henderson, better known as Joe Joe the HVAC Man, to explore the art and science of invasive diagnostics in the HVAC industry. With decades of experience and a passion for training, Joe Joe shares his expertise on how technicians can elevate their skills and improve system performance. We dive into: • The importance of understanding saturation temperatures over pressures in diagnostics • How proper airflow and clean components are the foundation of system efficiency • Techniques for using temperature measurements to diagnose systems without gauges • The evolution of refrigerants and their impact on system design and performance • Practical tips for identifying restrictions, optimizing airflow and ensuring accurate commissioning Joey provides actionable advice and takeaways for HVAC technicians, trainers and industry pros looking to refine their diagnostic approach and deliver top-notch service. Whether you're a seasoned tech or just starting out, this episode is a must-listen for anyone passionate about the HVAC trade. Reach out to Joe Joe at joejoethehvacman@gmail.com.

In this episode of The Digital Executive, host Brian Thomas sits down with Dr. Hany Demian, physician innovator, regenerative medicine pioneer, and CEO of the Biop Spine Institute. With over 20 years of experience treating chronic pain, Dr. Demian has shifted away from traditional pain management toward a groundbreaking model that blends AI-driven diagnostics, cellular-level therapies, and microinvasive procedures—all aimed at restoring the body rather than simply masking symptoms.Dr. Demian shares the personal and professional turning point that pushed him to transform his approach: patients repeatedly returning with the same pain, coupled with his own struggles with chronic spine and joint issues. This inspired his mission to move beyond management and into true healing. Today, his clinics combine biologic treatments such as stem cells, PRP, and peptides with data-guided rehabilitation and AI-based predictive modeling that assesses lifestyle, genetics, wearables, inflammation markers, and more.He explains how AI is unlocking unprecedented insights—predicting who will develop back pain, how quickly degeneration will occur, and which interventions will work best. Inspired by early breakthroughs in AI-driven cardiac prediction, Dr. Demian believes spine and joint care will soon shift from reactive to proactive, catching problems 5–10 years before they become symptomatic.Looking ahead, Dr. Demian envisions a radical shift in musculoskeletal care:Regenerative therapies as first-line treatmentNear elimination of traditional pain clinicsFewer surgeries due to earlier detection and cellular repairWidespread reversal of aging-related degenerationHe predicts a future where aging becomes a “modifiable condition,” supported by advanced stem cell treatments, peptides, exosomes, genetic insights, and healthier lifestyle habits now emerging in younger generations.Dr. Demian's optimistic, science-backed vision points toward a world where chronic pain is rare, mobility is preserved, and humans age healthier and stronger than ever before.A fascinating conversation for anyone interested in regenerative medicine, longevity, AI in healthcare, and the future of pain-free living.If you liked what you heard today, please leave us a review - Apple or Spotify.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

- Updates on AI Tools and Book Generator (0:10) - Health Advice and Lifestyle Habits (1:42) - Critique of Conventional Doctors (6:50) - The Rise of AI in Healthcare (10:05) - Better Than a Doctor AI Feature (17:24) - Health Ranger's AI and Robotics Projects (36:07) - Philosophical Discussion on AI and Human Rights (1:10:58) - The Future of AI and Human Interaction (1:17:53) - The Role of AI in Survival Scenarios (1:18:57) - The Potential for AI in Enhancing Human Life (1:19:13) - Personal Experience with AI and Health Data (1:19:32) - AI in Diagnostics and Natural Solutions (1:22:17) - Critique of Google and AI Ethics (1:25:00) - Impact of AI on Human Relationships and Society (1:30:24) - Debate on Consciousness and AI (1:35:54) - Historical and Scientific Perspectives on Consciousness (1:50:21) - Practical Applications and Future of AI (1:53:17) For more updates, visit: http://www.brighteon.com/channel/hrreport  NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Diagnostic intelligence is transforming healthcare by turning lab testing from a cost center into a strategic asset.  In this episode, Dr. Julie Schulz, Vice President of Product at Avalon Healthcare Solutions, discusses how integrating diagnostics into value-based care can lead to improved quality, lower costs, and enhanced preventive medicine. She notes that physicians are overwhelmed by the rapid growth of genetic testing and evolving clinical guidelines, leading to cognitive overload and inefficiencies. Diagnostic intelligence, she explains, can alleviate this by identifying the right tests at the right time and automating prior authorizations, reducing treatment timelines from 60 days to just 15. Dr. Schulz emphasizes that diagnostics inform 70% of healthcare decisions, making their effective use vital for improving access and outcomes, particularly among underserved populations, and underscores that simplifying data and embedding clinical decision support earlier can benefit both patients and providers. Tune in and learn how diagnostic intelligence is shaping the future of precision medicine and preventive care! Resources Connect with and follow Dr. Julie Schulz on LinkedIn. Follow Avalon Healthcare Solutions on LinkedIn and explore their website. Read Avalon Healthcare Solutions' Annual Lab Trend Report here.

Unnecessary broad-spectrum antibiotics can drive antimicrobial resistance and cause adverse events, whereas inadequate antibiotic coverage is linked to increased mortality and length of stay for patients with bloodstream infections (BSIs). Listen now to learn from Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP), how to use rapid genotypic and phenotypic antimicrobial susceptibility testing results to inform antibiotic selection for patients with gram-negative BSIs. Topics covered include:Typical patterns of intrinsic antibiotic susceptibility and resistance in EnterobacteralesMechanisms of resistance in gram-negative bacteriaGenotypic rapid diagnostic tests for BSIsResistance markers for earlier targeted therapyRapid phenotypic antimicrobial susceptibility test platforms for blood culturesPresenter:Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP)Medical and Public Health MicrobiologistMedical and Technical Director of MicrobiologyAdventHealthOrlando, FloridaLink to full program and downloadable slides:https://bit.ly/4inoXCxGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Download our “Tell a Better Story, Win Better Clients” E-book at https://working-towards.com/Dr. John Heinlein, Chief Marketing Officer at Sonatus, a global leader in vehicle software powering the shift toward software defined vehicles (SDVs) and AI-driven automotive innovation.John brings a unique blend of deep engineering expertise — with degrees from Carnegie Mellon University and a Ph.D. in Electrical Engineering from Stanford — and more than two decades of senior leadership across marketing, automotive technology, business development, and system architecture.We dig into:• How SDVs work and why vehicles are becoming more like data centers• The transition from 150+ hardware ECUs to flexible, upgradeable software platforms• How automakers harness vehicle data, intelligence, and AI to improve performance• The infrastructure needed to support next generation automotive experiences• The explosive role of AI in vehicle optimization, diagnostics, and personalization• Why the automotive industry is attracting top engineering talent again• Sonatus' rapidly growing footprint in more than 5 million production vehicles (soon to be 6 million)• The behind-the-scenes look at building a modern automotive software stackJohn also hosts The Garage by Sonatus, where he interviews top minds in vehicle software and mobility innovation.⸻Guest LinksWebsite: https://www.sonatus.com/LinkedIn: https://www.linkedin.com/in/johnheinlein/The Garage Podcast (YouTube): https://www.youtube.com/playlist?list=PL02SS1Fp5GCjBUmXe4eTnEVdDLDViQXR2